Key Insights

Highlights

Treatment Research

1 treatments under study, led by Zolpidem Viatris 10 Mg Comprimés Pelliculés

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Suspended1

Clinical Trials (1)

Showing 1 of 1 trials
SYF400c6b05021f48d9aebc7bd5d1175bf3Phase 2Suspended

Mechanisms of Action of Paradoxical Responses to Zolpidem: A Multimodal Study

Showing all 1 trials

Research Network

Common Treatments

  • Zolpidem Viatris 10 Mg Comprimés Pelliculés1

Active Sponsors

  • Universite De Liege1

Related Conditions

  • Neurotypical Volunteers Representing The General Population1
  • Patients With Disorders Of Consciousness Doc1

Activity Timeline